CompletedNot Applicable

Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes

Jordan18 participantsStarted 2015-01-01

Plain-language summary

This retrospective cohort study examines the effectiveness of minimally invasive spleen-preserving surgeries compared to total splenectomy for treating primary splenic hydatidosis in Jordan. Covering 18 patients from January 2015 to June 2021, the research highlights similar recurrence rates between both surgical approaches, emphasizing the benefits of spleen preservation in maintaining immune function and reducing septic risks, particularly in pediatric patients.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (age 14 years or older). * Diagnosed exclusively with primary, non-recurrent splenic hydatid cysts. Exclusion Criteria: * Children under 14 years of age. * Patients in late pregnancy. * Individuals with recurrent cysts. * Cases with extra-splenic involvement. * Patients with less than two years of postoperative follow-up.

What they're measuring

Incidence of Postoperative Short-Term Complications

Timeframe: Up to 1 month post-operation

Incidence of Postoperative Long-Term Complications

Timeframe: Up to 2 years post-operation

Trial details

NCT IDNCT06289816

SponsorYarmouk University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-06-30

View on ClinicalTrials.gov More Spleen-Preserving Surgery trials